Skip to main content
Log in

D-penicillamine-induced myositis in rheumatoid arthritis

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

D-penicillamine, an agent still used in the treatment of rheumatoïd arthritis (RA) may produce inflammatory myopathy or myositis. Some reported cases are documented with muscle biopsy. We report a 34-year old female, receiving the drug for more than 4 years, who consulted us with recently developed proximal muscle pain and weakness. EMG-findings were typical for inflammatory muscle disease; muscle enzymes remained normal. D-penicillamine was stopped and she was started on prednisolone with rapid improvement. The EMG-findings, with follow-up within three months, proved to be a good diagnostic tool, in the absence of laboratory muscle enzymes abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kagen Lawrence, J. Polymyositis / dermatomyositis. In: Arthritis and allied conditions. 12th ed. Eds.: McCarthy D.J., Koopman, W.J. Lea & Febiger 1993, 72, 1125–1150.

    Google Scholar 

  2. Morgan, G.J., McGuire, J.L., Ochoa, J. Penicillamine-induced myositis in rheumatoid arthritis. Muscle Nerve 1981, 4, 137–140.

    Article  PubMed  Google Scholar 

  3. Skosey John, J. Gold compounds and D-penicillamine. In: Arthritis and Allied Conditions. 12th ed. Eds.: Mc.Carty, D.J., Koopman, W.J. Lea & Febiger 1993, 32, 603–614.

    Google Scholar 

  4. Swash, M., Schwartz, M. Neuromuscular Diseases 2nd ed., Springer-Verlag 1988.

  5. Fernandes, L., Swinson, D.R., Hamilton, E.B.D. Dermatomyositis complicating penicillamine treatment. Ann Rheum Dis 1977, 36, 94–95.

    PubMed  Google Scholar 

  6. Cucher, G.B., Goldman, A.L. D-Penicillamine-induced polymyositis in rheumatoid arthritis. Ann Int Med 1977, 85, 615–616.

    Google Scholar 

  7. Heistercamp, F., Francx, M., Herregods, P., Dufoer, F., Joris, L., Mahler Ch., Chappel R. Myositis of niet-inflammatoire myopathie: een E.M.G.-ische diagnose? Medica Physica 1988, 11, 115–118.

    PubMed  Google Scholar 

  8. Bohan, A. et al. A computed-assisted analyses of 153 patients with polymyositis and dermatomyositis. Medicine 1977, 36, 235.

    Google Scholar 

  9. Andonopoulis, A.P., Terzis, E., Tsibri, E., Papasteriades, C.A., Papapetropoulos, T. D-Penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence. Clin Rheumatol 1994, 13, 586–588.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: Algemeen Ziekenhuis Middelheim Dienst Fysische Geneeskunde en Reumatologie Lindendreef 1 2020 Antwerpen, BELGIUM

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chappel, R., Willems, J. D-penicillamine-induced myositis in rheumatoid arthritis. Clin Rheumatol 15, 86–87 (1996). https://doi.org/10.1007/BF02231694

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02231694

Key words

Navigation